Mesoporous Silica in Biomedical Applications 2020

Dear Colleagues,

Since their discovery in the early 1990s, mesoporous silica materials have spurred significant research interest worldwide; especially so within the biomedical and pharmaceutical fields after the first reports on drug delivery appeared in the early 2000s, and nanoscaled syntheses of mesoporous silica were developed in parallel. The unique features of mesoporous silica have enabled the design of a wide range of biomedically relevant materials, whereby one or several functions can be integrated into the mesoporous silica system. In their nanoscale form, mesoporous silica nanoparticles (MSNs) have demonstrated applicability across all fields of nanomedicine ranging from nanopharmaceuticals to nanodiagnostics and regenerative medicine (tissue engineering). With bulk material becoming commercially available, the pharmaceutical industry has realized the potential of mesoporous silica, especially as enhancers for poorly soluble drugs as so-called ‘super-generics’. This Special Issue is devoted to the ever-expanding developments within the frames of the design, application, and further formulation of mesoporous silica materials for enabling the next generation of (nano)medical products and biomedical tools.

Prof. Jessica Rosenholm
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Mesoporous silica nanoparticles (MSNs)
• Drug delivery systems
• Nanomedicine
• Theranostics
• Multifunctionality
• Dosage form design
• Bioimaging
• Tissue engineering